What is RSV? RSV stands for respiratory syncytial virus. RSV is a common respiratory virus that infects the lungs and breathing passages. People most frequently associate RSV with the risks for young children, but it can also be very dangerous for older adults and people with pre-existing health conditions. Research has shown that RSV infections led to more hospitalisations in people with chronic conditions than people without these conditions. [1]
The purpose of the RSVoice study is to test an investigational vaccine for the prevention of RSV infection in adults who have chronic conditions or organ transplants. The investigational vaccine is a messenger RNA (mRNA) vaccine called mRNA-1345. It was developed by the pharmaceutical company Moderna.
The study is currently open at Aberdeen Royal Infirmary. People with congestive heart failure (CHF), coronary artery disease (CAD) and people who had organ transplants can take part. The local study team can be contacted via email: gram.vaccinetrial@nhs.scot
1 Respiratory syncytial virus infection in elderly and high-risk adults - PubMed (nih.gov)